Glaukos (GKOS) Other Non-Current Liabilities (2014 - 2026)
Glaukos' (GKOS) quarterly Other Non-Current Liabilities came in at $29.5 million in Q1 2026, up 38.48% year-on-year from $21.3 million in Q1 2025, and down 7.1% on a QoQ basis from $31.7 million in Q4 2025.
Glaukos (GKOS) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Other Non-Current Liabilities data on file, last reported at $29.5 million in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 38.48% year-over-year to $29.5 million in Q1 2026; TTM through Mar 2026 was $29.5 million, a 38.48% increase from a year earlier, with the FY2025 full-year figure at $31.7 million, up 41.87% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $29.5 million, down from $31.7 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for GKOS reached as high as $31.7 million in Q4 2025 and fell as low as $9.3 million in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $18.7 million across 5 years, with a median of $17.2 million in 2023.
- Across the five-year window, Other Non-Current Liabilities grew 5.71% in 2022 and surged 72.59% in 2024, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $10.3 million in 2022, then soared by 33.8% to $13.8 million in 2023, then jumped by 62.69% to $22.4 million in 2024, then surged by 41.87% to $31.7 million in 2025, then dropped by 7.1% to $29.5 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $29.5 million in Q1 2026, $31.7 million in Q4 2025, and $31.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.49 Mn |
| Dec 31, 2025 | 31.74 Mn |
| Sep 30, 2025 | 31.08 Mn |
| Jun 30, 2025 | 30.78 Mn |
| Mar 31, 2025 | 21.29 Mn |
| Dec 31, 2024 | 22.37 Mn |
| Sep 30, 2024 | 22.08 Mn |
| Jun 30, 2024 | 20.68 Mn |
| Dec 31, 2023 | 13.75 Mn |
| Sep 30, 2023 | 12.79 Mn |
| Jun 30, 2023 | 12.91 Mn |
| Mar 31, 2023 | 11.19 Mn |
| Dec 31, 2022 | 10.28 Mn |
| Sep 30, 2022 | 9.49 Mn |
| Jun 30, 2022 | 9.45 Mn |
| Mar 31, 2022 | 9.33 Mn |
| Dec 31, 2021 | 9.49 Mn |
| Sep 30, 2021 | 8.98 Mn |
| Jun 30, 2021 | 8.58 Mn |
| Mar 31, 2021 | 7.60 Mn |